Stocks and Investing
Stocks and Investing
Tue, November 15, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Stephen Baxter Maintained (AGL) at Buy with Decreased Target to $22 on, Nov 15th, 2022
Stephen Baxter of Wells Fargo, Maintained "agilon health, inc." (AGL) at Buy with Decreased Target from $28 to $22 on, Nov 15th, 2022.
Stephen has made no other calls on AGL in the last 4 months.
There are 4 other peers that have a rating on AGL. Out of the 4 peers that are also analyzing AGL, 0 agree with Stephen's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Stephen
- Whit Mayo of "SVB Leerink" Maintained at Buy with Decreased Target to $30 on, Friday, November 4th, 2022
- Sean Dodge of "RBC Capital" Initiated at Buy and Held Target at $33 on, Wednesday, September 14th, 2022
- Jailendra Singh of "Truist Securities" Initiated at Strong Buy with Decreased Target to $29 on, Wednesday, September 7th, 2022
- George Hill of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $30 on, Wednesday, August 3rd, 2022
Contributing Sources